At the Duncan Neurological Research Institute (Duncan NRI), the belief that the unsolvable can be solved drives every advancement. To mark 15 years of progress, physicians, researchers, donors and special guests recently gathered at the Houston Museum of Natural Science to recognize the Duncan NRI’s history of transforming laboratory insights into clinical action.
President and CEO Dr. Debbie Sukin delivered remarks about the Duncan NRI’s evolution into a global leader defined by a patient-focused approach. Founding Director Dr. Huda Y. Zoghbi noted that this vision fueled a rapid expansion from eight labs to 43 — now spanning neurodevelopmental, neurodegenerative and neuropsychiatric diseases in both children and adults — and highlighted the critical importance of philanthropy in advancing their work.
Since opening, the Duncan NRI team has identified the causes of nearly 100 rare conditions and transitioned seven treatment strategies into clinical trials. These milestones strengthen the Duncan NRI’s ability to tackle complex brain diseases, offering hope to patients and families around the world.
This progress is anchored by generous philanthropic and community advocates who partner in the research process. During the gala program, NBC News Chief Foreign Correspondent Richard Engel shared how his son’s journey helped advance the Duncan NRI’s research in Rett syndrome. Sadly, his son, Henry, died from the condition, but his legacy fuels the ongoing push for a cure, as researchers continue to study his cells. Eva Longoria, an actress and philanthropist, shared how her work with Eva’s Heroes, inspired by her sister, provides community support for individuals with intellectual disabilities. She also expressed her appreciation for the impact the Duncan NRI has on those facing neurological disorders.
“The Duncan NRI 15th Anniversary Gala raised more than $13 million and celebrated Dr. Zoghbi and her globally renowned team of award-winning scientists for the brilliant discoveries they have made, but this is only the beginning,” Vice President of Philanthropy Virginia Tomlinson said. “As they enter the next exciting chapter, they will continue solving the unsolvable and translating their discoveries into life-changing treatments.”
We are proud of our Duncan NRI team for the research breakthroughs and clinical advancements they continue to achieve. The team’s commitment is not only transforming how we treat complex neurological disorders, but it is also helping patients move past the limitations of their diagnoses toward a better quality of life.
Click here to view 15 neurological research advancements the Duncan NRI team has made.
